Bellevue Asset Management’s Haemonetics HAE Stock Holding History

Bellevue Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-43	Closed	-$3.45K	–	426
2025 Q4	$3.45K	Sell	43 -18	-30%	-$1.21K	﹤0.01%	380
2025 Q3	$2.97K	Buy	61 +12	+24%	+$743	﹤0.01%	395
2025 Q2	$3.65K	Hold	49	–	–	﹤0.01%	380
2025 Q1	$3.11K	Buy	49 +11	+29%	+$748	﹤0.01%	380
2024 Q4	$2.97K	Hold	38	–	–	﹤0.01%	409
2024 Q3	$3.05K	Hold	38	–	–	﹤0.01%	375
2024 Q2	$3.14K	Hold	38	–	–	﹤0.01%	364
2024 Q1	$3.24K	Hold	38	–	–	﹤0.01%	359
2023 Q4	$3.25K	Hold	38	–	–	﹤0.01%	351
2023 Q3	$3.4K	Hold	38	–	–	﹤0.01%	330
2023 Q2	$3.23K	Hold	38	–	–	﹤0.01%	352
2023 Q1	$3.14K	Buy	38 +4	+12%	+$324	﹤0.01%	360
2022 Q4	$2.65K	Hold	34	–	–	﹤0.01%	365
2022 Q3	$3K	Hold	34	–	–	﹤0.01%	347
2022 Q2	$2K	Hold	34	–	–	﹤0.01%	409
2022 Q1	$2K	Sell	34 -8	-19%	-$435	﹤0.01%	455
2021 Q4	$2K	Sell	42 -3	-7%	-$183	﹤0.01%	493
2021 Q3	$3K	Buy	45 +24	+114%	+$1.51K	﹤0.01%	457
2021 Q2	$1K	Sell	21 -2	-9%	-$142	﹤0.01%	569
2021 Q1	$3K	Sell	23 -3	-12%	-$371	﹤0.01%	507
2020 Q4	$3K	Buy	+26	New	+$2.8K	﹤0.01%	518

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bellevue Asset Management's HAE Position: Q1 2026 in Review

Bellevue Asset Management sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 43 shares — an estimated $3.45K sold.

Bellevue Asset Management first reported a position in HAE in Q4 2020 and held it in 21 quarters. The position peaked at $3.65K in Q2 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

Bellevue Asset Management reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
Bellevue Asset Management sold 43 Haemonetics shares in Q1 2026, an estimated $3.45K.
Bellevue Asset Management first reported a position in Haemonetics in Q4 2020 and held it in 21 quarters.
Bellevue Asset Management's Haemonetics position peaked at $3.65K in Q2 2025.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Bellevue Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.